- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
New line of attack: Immune system induces tumor dormancy
Tubingen, Germany - Researchers from Tubingen University have discovered that immune response can prevent tumor growth without killing tumor cells, according to ecancermedicalscience.
Tubingen, Germany
- Researchers from Tubingen University have discovered that immune response can prevent tumor growth without killing tumor cells, ecancermedicalscience reports.
Until now, scientists believed the immune system controlled tumor growth by killing cells, but researchers note immune responses can not only induce tumor dormancy, but also tumor growth, according to the study, published in Cancer Cell.
The study may lead to a new line of attack in the development of tumor vaccines.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
